Biogen Inc. (BIIB) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Thu March 4th, 2021

- 17:24
  Biogen To Build New Gene Therapy Facility With $200M InvestmentBenzinga

Tue March 2nd, 2021

- 07:20
  AnalysisBiogen Inc. (BIIB) CEO Michel Vounatsos Presents at Cowen 41st Annual Health Care Conference (Transcript)Seeking Alpha

Mon March 1st, 2021

- 22:11
  EarningsAnalysisDenali's (DNLI) Q4 Earnings & Revenues Beat on Biogen DealZacks
- 14:57
  AnalysisFUJIFILM Holdings: Beginning To Deliver On Healthcare DiversificationSeeking Alpha

Fri February 26th, 2021

- 02:27
  AnalysisWide-Moat Stocks On Sale - The March 2021 Heat MapSeeking Alpha

Tue February 23rd, 2021

- 13:30
  AnalysisBiogen And The Politics Of Alzheimer's DiseaseSeeking Alpha

Sat February 20th, 2021

- 15:10
  AnalysisWhy Piotroski's F-Score No Longer WorksSeeking Alpha

Thu February 18th, 2021

- 11:21
  AnalysisBiogen: High On HopeSeeking Alpha

Wed February 17th, 2021

- 16:11
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisTracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2020 UpdateSeeking Alpha

Tue February 16th, 2021

- 21:20
  AnalysisHealthcare Dashboard For February And Focus On IHFSeeking Alpha
- 13:00
  AnalysisApplied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye DiseasesSeeking Alpha

Fri February 12th, 2021

- 14:23
  AnalysisIs the FDA Delay Actually Good News for Biogen's Alzheimer's Drug?The Motley Fool
- 11:25
  AnalysisWhy Is Everyone Talking About Biogen Stock?The Motley Fool

Thu February 11th, 2021

- 14:13
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: Biogen, Gilead Sciences, Regeneron Pharma, Bristol-Myers Squibb and IncyteZacks

Mon February 8th, 2021

- 04:06
  AnalysisBiogen 2021: 2 Paths DivergeSeeking Alpha

Sat February 6th, 2021

- 18:52
  Barron's Picks And Pans: Amazon, Biogen, Casey's General Stores, Hilton And MoreBenzinga

Fri February 5th, 2021

- 13:00
  Press ReleasesBiogen Offers Arcadia's Home Renewable Energy Program to EmployeesPR Newswire

Thu February 4th, 2021

- 11:17
  Press ReleasesAnalysisAlzheimer's Association again endorses Biogen drug despite mystery data analysis and financial conflict of interest, says Dr. Leslie Norins of Alzheimer's Germ QuestPR Newswire

Wed February 3rd, 2021

- 18:25
  EarningsAnalysisBiogen Inc. (BIIB) CEO Michel Vounatsos on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha
- 18:01
  EarningsAnalysisBiogen Inc (BIIB) Q4 2020 Earnings Call TranscriptThe Motley Fool
- 17:52
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisBiogen (BIIB) Q4 Earnings Miss, Revenues Surpass EstimatesZacks
- 16:30
  AnalysisWhy Biogen's Q4 Results Were a BustThe Motley Fool
- 15:02
  EarningsAnalysisBiogen Inc. 2020 Q4 - Results - Earnings Call PresentationSeeking Alpha

Mon February 1st, 2021

- 14:40
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCan Biogen (BIIB) Keep the Earnings Streak Alive in Q4?Zacks

Sat January 30th, 2021

- 05:54
  AnalysisWill Biogen Get Tecfidera Patent Reinstated By Appeals Court?Seeking Alpha

Fri January 29th, 2021

Mon January 25th, 2021

- 21:30
  Press ReleasesWorldwide Biosimilars Industry to 2026 - Key Players Include Amgen, AXXO and Biogen Among OthersPR Newswire

Fri January 22nd, 2021

Wed January 20th, 2021

- 19:06
  AnalysisHealthcare Review Starting In 2021 And Focus On PTHSeeking Alpha + 2 more

Fri January 15th, 2021

- 15:39
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: PayPal, Exxon Mobil, Goldman Sachs, Charter Communications and BiogenZacks

Thu January 14th, 2021

- 20:38
  AnalysisAmerican BriVision: Deep Dive Into Market PotentialSeeking Alpha

Wed January 13th, 2021

- 14:35
  Press ReleasesAnalysisDiamondback Energy, Ryman Hospitality Properties, Eli Lilly, Biogen and Roche highlighted as Zacks Bull and Bear of the DayZacks
- 13:00
  AnalysisGuide4 Reasons Cassava Sciences Could Be The Best-Performing Stock Of 2021Seeking Alpha + 1 more

SPY$383.951.9%

QQQ$309.071.6%

DOW$62.732.5%

AAPL$121.491.1%

GOOG$2,109.83%

INTC$614.6%

TSLA$596.25-4.1%

SPY$383.951.9%

QQQ$309.071.6%

DOW$62.732.5%

AAPL$121.491.1%

GOOG$2,109.83%

INTC$614.6%

TSLA$596.25-4.1%

About Developer Contact